Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Journal of Pharmaceutical Sciences
|
October 1, 1981
Human blood preservation: effect on in vitro protein binding
A J Jackson, A K Miller, P K Narang
European Journal of Drug Metabolism and Pharmacokinetics
|
January 26, 2002
Induction of hepatic and presystemic metabolism of antipyrine in the mice: rifampicin versus rifabutin
X G Liu, P K Narang, R C Li
Journal of Clinical Pharmacology
|
October 1, 1993
Concentration-dependent protein binding of a novel oral thromboxane synthase inhibitor--FCE 22,178
R C Li, D T Rossi, P K Narang
The American Journal of Physiology
|
February 1, 1985
Kinetic model for disposition of 6-mercaptopurine in monkey plasma and cerebrospinal fluid
D G Covell, P K Narang, D G Poplack
Die Pharmazie
|
May 1, 1978
Long acting methadone formulations
N H Choulis, L Abellana-Intaphan, P K Narang
Journal of Chromatography
|
July 9, 1982
Quantitation of 6-mercaptopurine in biologic fluids using high-performance liquid chromatography: a selective and novel procedure
P K Narang, R L Yeager, D C Chatterji
Biopharmaceutics & Drug Disposition
|
April 1, 1996
A model based assessment of redistribution dependent elimination and bioavailability of rifabutin
R C Li, P K Narang, I Poggesi, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1988
Steady-state cerebrospinal fluid transfer of verapamil and metabolites in patients with schizophrenia
P K Narang, C L Blumhardt, A R Doran, et al.
Journal of Pharmaceutical Sciences
|
December 1, 1983
Quantitation of ketoconazole in biological fluids using high-performance liquid chromatography
V L Pascucci, J Bennett, P K Narang, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration
L J Lesko, P K Narang, L Yeager, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Journal of Pharmaceutical Sciences
|
October 1, 1981
Human blood preservation: effect on in vitro protein binding
A J Jackson, A K Miller, P K Narang
European Journal of Drug Metabolism and Pharmacokinetics
|
January 26, 2002
Induction of hepatic and presystemic metabolism of antipyrine in the mice: rifampicin versus rifabutin
X G Liu, P K Narang, R C Li
Journal of Clinical Pharmacology
|
October 1, 1993
Concentration-dependent protein binding of a novel oral thromboxane synthase inhibitor--FCE 22,178
R C Li, D T Rossi, P K Narang
The American Journal of Physiology
|
February 1, 1985
Kinetic model for disposition of 6-mercaptopurine in monkey plasma and cerebrospinal fluid
D G Covell, P K Narang, D G Poplack
Die Pharmazie
|
May 1, 1978
Long acting methadone formulations
N H Choulis, L Abellana-Intaphan, P K Narang
Journal of Chromatography
|
July 9, 1982
Quantitation of 6-mercaptopurine in biologic fluids using high-performance liquid chromatography: a selective and novel procedure
P K Narang, R L Yeager, D C Chatterji
Biopharmaceutics & Drug Disposition
|
April 1, 1996
A model based assessment of redistribution dependent elimination and bioavailability of rifabutin
R C Li, P K Narang, I Poggesi, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1988
Steady-state cerebrospinal fluid transfer of verapamil and metabolites in patients with schizophrenia
P K Narang, C L Blumhardt, A R Doran, et al.
Journal of Pharmaceutical Sciences
|
December 1, 1983
Quantitation of ketoconazole in biological fluids using high-performance liquid chromatography
V L Pascucci, J Bennett, P K Narang, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration
L J Lesko, P K Narang, L Yeager, et al.
Page
of 6